Shaji Kumar, MD, on Ventoclax Monotherapy for Multiple Myeloma

Dr. Kumar sat down with Clinical Oncology News to discuss his presentation, “Venetoclax Monotherapy for Relapsed/Refractory Multiple Myeloma: Safety and Efficacy Results from a Phase I Study” (abstract 288).